994 Federal Register / Vol. 75, No. 4 / Thursday, January 7, 2010 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Therapeutics Partnerships. 

Date: January 26–27, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Hotel—Silver Spring, 

8777 Georgia Avenue, Silver Spring, MD 

20910. 

Contact Person: Lynn Rust, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, NIAID/ 

NIH/DHHS, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892, (301) 402–3938, 

lr228v@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Diagnostics Partnerships. 

Date: February 11, 2010. 

Time: 10 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge 6700, 6700B Rockledge Drive, 

Bethesda, MD 20817. 

Contact Person: Lynn Rust, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, NIAID/ 

NIH/DHHS, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892, (301) 402–3938, 

lr228v@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 30, 2009. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–41 Filed 1–6–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cell Biology. 

Date: January 26–27, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Jonathan Arias, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5170, 

MSC 7840, Bethesda, MD 20892, 301–435– 

2406, ariasj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; HT Member 

Conflict. 

Date: January 28, 2010. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Delia Tang, MD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4126, MSC 7802, Bethesda, MD 

20892, 301–435–2506, tangd@csr.nih.gov. 

Name of Committee: Emerging 

Technologies and Training; Neurosciences 

Integrated Review Group. Neurotechnology 

Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Robert C. Elliott, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892, 301–435– 

3009, elliotro@csr.nih.gov. 

Name of Committee: Oncology 2— 

Translational Clinical Integrated; Review 

Group. Chemo/Dietary Prevention Study 

Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Hotel—Silver Spring, 

8777 Georgia Avenue, Silver Spring, MD 

20910. 

Contact Person: Sally A. Mulhern, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

5877, mulherns@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Cellular Signaling 

and Regulatory Systems Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Fairmont Hotel, 2401 M Street, NW., 

Washington, DC 20037. 

Contact Person: Elena Smirnova, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5187, 

MSC 7840, Bethesda, MD 20892, 301–357– 

9112, smirnove@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group; Language and Communication Study 

Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont San Francisco, 950 

Mason Street, San Francisco, CA 94108. 

Contact Person: Weijia Ni, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 3184, MSC 7848, Bethesda, MD 

20892, (301) 237–9918, niw@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review; Group 

Neurological, Aging and Musculoskeletal 

Epidemiology Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel, 1515 Rhode Island 

Avenue, NW., Washington, DC 20005. 

Contact Person: Heidi B. Friedman, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1012A, 

MSC 7770, Bethesda, MD 20892, 301–435– 

1721, hfriedman@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Psychosocial Development, Risk and 

Prevention Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Washington, DC, 400 

New Jersey Avenue, NW., Washington, DC 

20001. 

Contact Person: Anna L. Riley, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

Federal Register / Vol. 75, No. 4 / Thursday, January 7, 2010 / Notices 995 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7759, Bethesda, MD 20892, 301–435– 

2889, rileyann@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Developmental Brain Disorders Study 

Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 W. Mission 

Bay Drive, San Diego, CA 92109. 

Contact Person: Pat Manos, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5200, MSC 7846, Bethesda, MD 

20892, 301–408–9866, manospa@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review; Group 

Infectious Diseases, Reproductive Health, 

Asthma and Pulmonary Conditions Study 

Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Coronado Island Marriott Resort & 

Spa, 2000 Second Street, Coronado, CA 

92118. 

Contact Person: Jose Fernando Arena, PhD, 

MD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3135, 

MSC 7770, Bethesda, MD 20892, 301–435– 

1735, arenaj@mail.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group; Molecular 

Genetics C Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Contact Person: Barbara Whitmarsh, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2206, 

MSC 7890, Bethesda, MD 20892, 301/435– 

4511, whitmarshb@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neural Oxidative Metabolism 

and Death Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Ritz Carlton Hotel, 1150 22nd Street, 

NW., Washington, DC 20037. 

Contact Person: Carol Hamelink, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7850, Bethesda, MD 20892, (301) 213– 

9887, hamelinc@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neurogenesis and Cell Fate 

Study Section. 

Date: February 4, 2010. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis Hotel, 335 

Powell Street, San Francisco, CA 94102. 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1257, baizerl@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group; 

Host Interactions with Bacterial Pathogens 

Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance Mayflower Hotel, 1127 

Connecticut Avenue, NW., Washington, DC 

20036. 

Contact Person: Fouad A. El-Zaatari, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

1149, elzaataf@csr.nih.gov. 

Name of Committee: Cell Biology 

Integrated Review Group; Molecular and 

Integrative Signal Transduction Study 

Section. 

Date: February 4, 2010. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Raya Mandler, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5134, 

MSC 7840, Bethesda, MD 20892, (301) 402– 

8228, rayam@csr.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review; 

Group Pathophysiological Basis of Mental 

Disorders and Addictions Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Fairmont Washington, DC, 2401 M 

Street, NW., Washington, DC 20037. 

Contact Person: Boris P. Sokolov, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217A, 

MSC 7846, Bethesda, MD 20892, 301–408– 

9115, bsokolov@csr.nih.gov. 

Name of Committee: Population Sciences 

and Epidemiology Integrated Review; Group 

Kidney, Nutrition, Obesity and Diabetes 

Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Palomar Washington, DC, 

2121 P Street, NW., Washington, DC 20037 

Contact Person: Fungai Chanetsa, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3135, 

MSC 7770, Bethesda, MD 20892, 301–408– 

9436, fungai.chanetsa@nih.hhs.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review; 

Group Neural Basis of Psychopathology, 

Addictions and Sleep Disorders Study 

Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Nikko San Francisco, 222 

Mason Street, San Francisco, CA 94102. 

Contact Person: Julius Cinque, MS, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1252, cinquej@csr.nih.gov. 

Name of Committee: Risk, Prevention and 

Health Behavior Integrated Review Group; 

Behavioral Medicine, Interventions and 

Outcomes Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Catamaran Resort Hotel and Spa, 

3999 Mission Boulevard, San Diego, CA 

92109. 

Contact Person: Lee S. Mann, JD, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3186, 

MSC 7848, Bethesda, MD 20892, 301–435– 

0677, mannl@csr.nih.gov. 

Name of Committee: Oncology 1—Basic 

Translational Integrated Review Group; 

Cancer Genetics Study Section. 

Date: February 4–5, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Delfina Santa Monica, 530 

West Pico Boulevard, Luna, Santa Monica, 

CA 90405. 

Contact Person: Steven F. Nothwehr, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5183, 

MSC 7840, Bethesda, MD 20892, 301–435– 

2492, nothwehrs@mail.nih.gov. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group Clinical Neuroimmunology and Brain 

Tumors Study Section. 

Date: February 4–5, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bahia Resort Hotel, 998 W. Mission 

Bay Drive, San Diego, CA 92109. 

Contact Person: Jay Joshi, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5196, MSC 7846, Bethesda, MD 

20892, (301) 408–9135, joshij@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group; 

Pathogenic Eukaryotes Study Section. 

Date: February 4–5, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Melrose Hotel, Washington, DC, 

2430 Pennsylvania Avenue, NW., 

Washington, DC 20037. 

Contact Person: Tera Bounds, DVM, PhD, 

Scientific Review Officer, Center for 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES

996 Federal Register / Vol. 75, No. 4 / Thursday, January 7, 2010 / Notices 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3198, 

MSC 7808, Bethesda, MD 20892, 301–435– 

2306, boundst@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies; Community-Level Health 

Promotion Study Section. 

Date: February 4–5, 2010. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Monaco, 495 Geary Street, San 

Francisco, CA 94102. 

Contact Person: Jacinta Bronte-Tinkew, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3164, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1503, brontetinkewjm@csr.nih.gov. 

Name of Committee: Biobehavioral and 

Behavioral Processes Integrated Review 

Group Adult Psychopathology and Disorders 

of Aging Study Section. 

Date: February 4–5, 2010. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Estina E. Thompson, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892, 301–496– 

5749, thompsone@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Neurotechnology 2. 

Date: February 5, 2010. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Robert C. Elliott, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892, 301–435– 

3009, elliotro@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 30, 2009. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–35 Filed 1–6–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Medicare Prescription Drug, 

Improvement, and Modernization Act 

of 2003 Section 1013: Request for 

Nominations—The Effective Health 

Care Stakeholder Group 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), DHHS. 

ACTION: Notice of invitation to submit 

nominations for the Effective Health 

Care Stakeholder Group. 

SUMMARY: The DHHS Agency for 

Healthcare Research and Quality 

(AHRQ) invites nominations from 

interested organizations and 

knowledgeable individuals for members 

of the Stakeholder Group to support the 

work of the Effective Health Care 

Program, established [for consultation] 

pursuant to Section 1013 of the 

Medicare Prescription Drug, 

Improvement, and Modernization Act 

(MMA) of 2003. The goals of this 

program are to develop evidence on the 

effectiveness and comparative 

effectiveness of different treatments and 

health care interventions of importance 

to the Medicare, Medicaid, and State 

Child Health Insurance programs. To 

achieve these goals, AHRQ supports 

projects to review, synthesize, generate, 

and translate scientific evidence, as well 

as identify important issues for which 

existing scientific evidence is 

insufficient to inform decisions about 

health care. The Effective Health Care 

Program makes the evidence 

information it develops readily available 

to health care decision makers. The 

Stakeholder Group is critical to the 

success of the Effective Health Care 

Program by providing input to improve 

the applicability and relevance of 

research products to health care 

decision makers. The Effective Health 

Care Program Stakeholder Group will be 

a part of the Citizen’s Forum initiative, 

funded by the American Recovery and 

Reinvestment Act, to formally and 

broadly engage stakeholders, and to 

enhance and expand public 

involvement in the entire Effective 

Health Care enterprise. 

The role of the Stakeholder Group will 

be to: 

• Provide guidance on program 

implementation including: 

i. Quality improvement. 

ii. Opportunities to maximize impact 

and expand program reach. 

iii. Ensuring stakeholder interests are 

considered and included. 

iv. Evaluating success. 

• Provide input on implementing 

Effective Health Care Program reports 

and findings in practice and policy 

settings. 

• Identify options and recommend 

solutions to issues identified by 

Effective Health Care Program staff. 

• Provide input on critical research 

information gaps for practice and 

policy, as well as research methods to 

address them. Specifically: 

i. Information needs and types of 

products most useful to consumers, 

clinicians and policy makers. 

ii. Feedback on Effective Health Care 

Program reports, reviews and summary 

guides. 

iii. Scientific methods and 

applications. 

• Champion objectivity, 

accountability and transparency in the 

Effective Health Care program. 

Members will serve as volunteers for 

a two-year period from summer 2010 

through summer 2012. Stakeholder 

Group members will attend 3–4 

meetings per year in Rockville, MD, and 

possibly other cities to be determined. 

Meetings will be 1–2 days in length, and 

AHRQ or a group designated by AHRQ 

will be responsible for travel planning 

and expenses. The first meeting will be 

held in late summer or early fall 2010 

in Rockville, MD. 

Members are expected to actively 

participate in meetings and to engage in 

related activities by phone and e-mail 

between meetings. Between-meeting 

work may include reviewing and 

providing input on the overall product 

development strategy and direction for 

the Effective Health care program, 

consulting with AHRQ staff on 

constituency issues, and serving as a 

resource to the Program. It is anticipated 

that the Stakeholder Group member 

time commitment between meetings 

will not exceed 10 hours. 

The Stakeholder Group will be 

composed of up to 20 members with a 

diversity of perspectives and opinions. 

The group will represent several broad 

constituencies of stakeholders and 

decision-makers at the policy, system, 

and clinical levels, which will include: 

• Patient/caregiver/consumer. 

• Consumers of Federal and State 

beneficiary programs. 

• Healthcare providers. 

• Third party healthcare payers 

(including, but not limited to public 

State or Federal Medicare or Medicaid 

programs, and private insurance health 

plans and Health Maintenance 

Organizations). 

• Employers and health-related 

businesses. 

• Pharmacy and therapeutic 

committees. 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES